WuXi AppTec (OTCMKTS:WUXAY) Shares Gap Up – Still a Buy?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) gapped up prior to trading on Tuesday . The stock had previously closed at $18.50, but opened at $19.3550. WuXi AppTec shares last traded at $19.3550, with a volume of 121 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded WuXi AppTec to a “hold” rating in a research note on Monday, April 13th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, WuXi AppTec presently has an average rating of “Moderate Buy”.

WuXi AppTec Trading Up 0.9%

The business has a 50 day simple moving average of $16.73 and a two-hundred day simple moving average of $15.28.

WuXi AppTec (OTCMKTS:WUXAY) last announced its earnings results on Monday, April 27th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The business had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.